Research Journal of Pharmacy and Technology
SCOPUS
  • Year: 2023
  • Volume: 16
  • Issue: 8

New synthetic methods of ureido-substituted benzenesulfonamides as carbonic anhydrase IX inhibitors

  • Author:
  • Mohammad Hasbi Ghazal1, Djamila Ben Hadda2, Saleh Trefi1, Amir Balash3, Mustapha Fawaz Chehna1,*
  • Total Page Count: 7
  • Page Number: 3884 to 3890

1Department of Pharmaceutical Chemistry and Drug Control, Faculty of Pharmacy, University of Aleppo, Aleppo, Syria

2Department of Pharmaceutical Chemistry and Drug Control, Faculty of Pharmacy, Ebla Private University, Aleppo, Syria

3Department of Pharmaceutical Chemistry, Institute of Pharmacy, University of Marburg, Marburg, Germany

*Corresponding Author E-mail: hasbigazal@hotmail.com

Online Published on 2 November, 2023.

Abstract

Human Carbonic anhydrase IX is often found to be over-expressed in solid tumors, and plays a role in helping cancer cells adapt and grow under Hypoxic conditions, by exacerbating the extracellular acidification which enables cancer cells to develop resistance against chemotherapy. Many molecules were studied as CAIX inhibitors. Ureido-Substituted benzenesulfonamides (UBSs) are promising CA IX inhibitors to be used in cancer treatments. (SLC-0111) is one of the (UBSs) that has shown tolerability and safety in patients previously Treated for tumors. The most common preparation method of these derivatives in the pharmaceutical industry is based on using toxic phosgene. (2-b), (SLC-0111), and (2-d) were synthesized by three phosgene-free methods of preparation in yields ranging between 30, 50, and 80% according to the used solvent.when acidic water is used as the solvent, impurities are formed as a result of a secondary reaction ,while, butanol is much suitable for synthesizing the desired compounds selectively.

Keywords

CA IX enzyme, CA IX Inhibitors, Anti-tumor agents, Ureido-substituted benzenesulfonamide, Phosgene-free